Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Author: Justin Klein

Vensana in the News

Medtech investor duo seeks to ‘fill the gap’ in device sector private funding

Vensana in the News

New Minnesota-based fund has $225 million to invest in young med-tech companies

22

Novel FDA PMA & de novo 510k approvals

61

U.S. Commercial Product Launches

40

Level I Clinical Trials

34

Strategic Financings

31

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
Luna Diabetes Raises Series A Financing to Advance its Automated Insulin Delivery Solution For Insulin Pen Users
Vensana Capital Welcomes Maria Berkman as Partner and Ross (Rusty) Segan as Venture Partner
SpyGlass Pharma Raises $75 Million Series D Funding to Advance Its Long-term Drug Delivery Platform for Glaucoma Patients
Resources
News LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 7900 Tysons One Place Suite 320 McLean, VA 22102

© 2025 Vensana Capital Management, LLC | Privacy | Terms & Conditions